Accendra Health Statistics
Total Valuation
Accendra Health has a market cap or net worth of $73.13 million. The enterprise value is $1.89 billion.
| Market Cap | 73.13M |
| Enterprise Value | 1.89B |
Important Dates
The last earnings date was Monday, August 10, 2026, before market open.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Accendra Health has 76.90 million shares outstanding. The number of shares has decreased by -0.47% in one year.
| Current Share Class | 76.90M |
| Shares Outstanding | 76.90M |
| Shares Change (YoY) | -0.47% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 9.42% |
| Owned by Institutions (%) | 66.44% |
| Float | 56.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.16 |
| PS Ratio | 0.03 |
| Forward PS | 0.03 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.71 |
| EV / EBITDA | 6.54 |
| EV / EBIT | 58.63 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.41
| Current Ratio | 0.41 |
| Quick Ratio | 0.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.89 |
| Debt / FCF | n/a |
| Interest Coverage | 0.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 0.64% |
| Return on Invested Capital (ROIC) | 2.42% |
| Return on Capital Employed (ROCE) | 2.23% |
| Weighted Average Cost of Capital (WACC) | 5.17% |
| Revenue Per Employee | $407,268 |
| Profits Per Employee | -$46,483 |
| Employee Count | 6,500 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 20.49 |
Taxes
| Income Tax | -4.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.16% in the last 52 weeks. The beta is 1.61, so Accendra Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -82.16% |
| 50-Day Moving Average | 3.01 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 18.50 |
| Average Volume (20 Days) | 1,440,025 |
Short Selling Information
The latest short interest is 5.33 million, so 6.92% of the outstanding shares have been sold short.
| Short Interest | 5.33M |
| Short Previous Month | 5.86M |
| Short % of Shares Out | 6.92% |
| Short % of Float | 9.42% |
| Short Ratio (days to cover) | 10.15 |
Income Statement
In the last 12 months, Accendra Health had revenue of $2.65 billion and -$302.14 million in losses. Loss per share was -$3.95.
| Revenue | 2.65B |
| Gross Profit | 1.19B |
| Operating Income | 32.16M |
| Pretax Income | -115.48M |
| Net Income | -302.14M |
| EBITDA | 288.23M |
| EBIT | 32.16M |
| Loss Per Share | -$3.95 |
Balance Sheet
The company has $7.65 million in cash and $1.82 billion in debt, with a net cash position of -$1.81 billion or -$23.56 per share.
| Cash & Cash Equivalents | 7.65M |
| Total Debt | 1.82B |
| Net Cash | -1.81B |
| Net Cash Per Share | -$23.56 |
| Equity (Book Value) | -550.94M |
| Book Value Per Share | -7.16 |
| Working Capital | -394.77M |
Cash Flow
In the last 12 months, operating cash flow was -$180.42 million and capital expenditures -$176.77 million, giving a free cash flow of -$357.19 million.
| Operating Cash Flow | -180.42M |
| Capital Expenditures | -176.77M |
| Depreciation & Amortization | 256.08M |
| Net Borrowing | -135.00M |
| Free Cash Flow | -357.19M |
| FCF Per Share | -$4.64 |
Margins
Gross margin is 44.83%, with operating and profit margins of 1.21% and -11.41%.
| Gross Margin | 44.83% |
| Operating Margin | 1.21% |
| Pretax Margin | -4.36% |
| Profit Margin | -11.41% |
| EBITDA Margin | 10.89% |
| EBIT Margin | 1.21% |
| FCF Margin | n/a |
Dividends & Yields
Accendra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.47% |
| Shareholder Yield | 0.47% |
| Earnings Yield | -413.16% |
| FCF Yield | -488.44% |
Analyst Forecast
The average price target for Accendra Health is $1.51, which is 58.80% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.51 |
| Price Target Difference | 58.80% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -0.96% |
| EPS Growth Forecast (3Y) | -28.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 1, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Apr 1, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Accendra Health has an Altman Z-Score of 0.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.37 |
| Piotroski F-Score | 3 |